Status:
TERMINATED
Cell Content of Sputum Induced by Hypertonic Saline in Adolescents With Cystic Fibrosis
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
Cystic fibrosis requires regular monitoring of bacterial colonization of sputum. The collection is done during scheduled consultations or urgently during exacerbations during the respiratory physiothe...
Eligibility Criteria
Inclusion
- Adolescent between 12 and 17 years old with definite cystic fibrosis (two CFTR gene mutations identified and positive sweat test)
- Patient followed at the pediatric CRCM of Marseille
- Patient able to expectorate spontaneously and master autogenous drainage
- Patient in stable clinical condition for 1 month
Exclusion
- Patient refusing the study
- Patient under systemic antibiotic therapy
- Patient with respiratory decompensation or upper airway infection
- Patient with oxygen saturation \< 92% before nebulization
- Patient with hemoptysis in the last 3 months
- Patients with decompensated heart failure
Key Trial Info
Start Date :
July 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2021
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06909903
Start Date
July 20 2021
End Date
October 10 2021
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Médecine Physique et réadaptation - CHU Timone Enfants
Marseille, France, France, 13385